Near-Infrared Light and Upconversion Nanoparticle Defined Nitric Oxide-Based Osteoporosis Targeting Therapy
Authors:
- 30 July 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 15 (8) , 13692-13702
Abstract
Osteoporosis is one of the most common diseases affecting bone metabolism. Nitric oxide (NO), an endogenous gas molecule involved in osteogenesis, can effectively promote the proliferation and differentiation of osteoblasts. Although exogenous NO can reverse osteoporosis to a certain extent, the transitory half-life and short diffusion radius of NO severely limit its application. In this work, a gas generation nanoplatform of NO with bone targeting property (UCPA) is developed based on the upconversion nanoparticles (UCNPs) that can convert 808 nm near-infrared (NIR) light into UV/blue light, and further stimulate the NO donor (BNN) to release NO. With an adjustment of the output power of the 808 nm NIR, the amount of released NO can be precisely controlled. Both in vitro and in vivo experiments demonstrate the favorable affinity of UCPA to bone due to the modification of alendronate; thus, it can directly release NO in bone and reverse osteoporosis. In addition, the cellular uptake of nanocomposites and intracellular NO release can be observed in preosteoblasts, thereby promoting their differentiation efficiently.Keywords
Funding Information
- National Natural Science Foundation of China (31860263, 81760408)
- Natural Science Foundation of Jiangxi Province (20113BCB22005, 20181BCG42001)
- Graduate Innovation Special Fund of Jiangxi Province (YC2020-B051)
- Key Youth Project of Jiangxi Province (20202ACB216002)
- National Key Research and Development Program of China (2020YFC2005800)
This publication has 31 references indexed in Scilit:
- Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis TreatmentACS Nano, 2019
- Nitrates and osteoporosis: Which relationship?European Journal of Internal Medicine, 2017
- Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized RatsPLOS ONE, 2016
- NIR light controlled release of caged hydrogen sulfide based on upconversion nanoparticlesChemical Communications, 2015
- Nitric oxide release: Part II. Therapeutic applicationsChemical Society Reviews, 2012
- Nitric oxide: novel therapy for osteoporosisExpert Opinion on Pharmacotherapy, 2008
- Age-Related Bone Mineral Density, Bone Loss Rate, Prevalence of Osteoporosis, and Reference Database of Women at Multiple Centers in ChinaJournal of Clinical Densitometry, 2007
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Nitric Oxide Donors: Chemical Activities and Biological ApplicationsChemical Reviews, 2002
- Nitric oxide and the immune responseNature Immunology, 2001